Safety and Efficacy of Unwashed Filtered Wound Drainage Blood Reinfused Following Orthopaedic Surgery
Autologous blood products are being used increasingly to fulfill the needs of patients undergoing orthopaedic and other surgical procedures. The major impetus for this practice is the concern about potential risks associated with homologous blood, e.g. the transmission of blood-borne infectious agents such as human immunodeficiency virus (HIV) and hepatitis viruses.
Autologous blood collected prior to surgery and shed blood collected intraoperatively and postoperatively are being used in place of homologous blood.1,2,3 Shed blood from orthopaedic wounds may be contaminated with fat particles, bone fragments, and methylmethacrylate monomer.
Shed blood may also contain increased levels of plasma hemoglobin and fibrin degradation products as a result of hemolysis and clot lysis, and orthopaedic shed blood may also contain products of platelet and complement activation.1,2,3 Although shed blood is filtered before reinfusion, there are opposing views on whether or not washing is necessary.
This randomized, prospective clinical trial in 128
patients was undertaken to evaluate shed blood recovered after hip or knee replacement, or spinal fusion surgery.
The effects of the reinfusion of shed blood collected postoperatively by two autotransfusion systems were compared with the effects of the transfusion of liquid preserved autologous and homologous blood. 4 .
MATERIALS AKD METHODS
One-hundred twenty-eight orthopaedic patients at four medical centers were randomized for study-Surgical procedures included total knee replacement, total hip replacement or spinal fusion. Written informed consent was obtained from each study subject. This was a randomized study of a) patients in whom shed blood was collected using one of two wound drainage systems, the Orth-evacTM or the SolcotransR, and reinfused postoperatively using the Pall 40 micron screen filter or the Pall RC100 polyester filter, and b) patients who did not receive shed blood but received autologous or homologous liquid preserved red blood cells.
The patients who did not receive shed blood were treated with a standard wound drainage system (hemovac) and received homologous or autologous liquid preserved red blood cells.
Drainage catheters were placed in each patient using conventional surgical methods according to the manufacturer's directions. With the Solcotrans drainage system, forty (40) ml of acid citrate dextrose (ACD, NIH Formula A) was used; no anticoagulant was added with the Orth-evac drainage system. In 24 patients at one medical center, methylmethacrylate was measured in the shed blood five minutes after insertion of the knee prosthesis and in the patient one hour and 24 hours after reinfusion of the shed blood.13,14 All patients were closely monitored through measurements of blood pressure, heart rate, respiration rate, and temperature, after surgery and after reinfusion of the shed blood. Any adverse reactions or complications were recorded.
DATA ANALYSIS:
The means and standard deviations are reported. T-tests were used to compare data collected on the patients who received shed blood and the patients who received autologous and homologous liquid preserved red blood cells. Comparisons of data collected prior to and following the reinfusion of shed postoperative drainage were made using analysis of variance.15
RESULTS
All the patients in the study were of similar age, height, weight, and sex (Table 1) , and types of surgical procedures to which the patients were subjected were similar ( Table 2) .
Nine of 84 patients from whom shed blood was collected
were not reinfused and were excluded from the study: eight patients because the drainage collected was less than 250 ml, and one patient because the shed blood was stored at room temperature for longer than 6 hours.
The last 50 ml of shed blood collected was not reinfused because this portion of the shed blood is known to contain fat particles.
The patients who received 338 ml of shed blood collected in the Orth-evac system and the patients who received 336 ml of shed blood collected in the Solcotrans system also received autologous and homologous liquidpreserved red blood cells (Table 3, 4) . Figure 1 reports the total volume of shed blood collected from each patient in the study.
Of 35 patients who received no shed blood, seven (7) were transfused with homologous liquid preserved blood and eight (8) received both homologous and autologous red blood cells (Table 4 ). Six (6) (Table 5 ).
Fibrinogen and antiplasmin levels were lower and Factor VIII and thrombin levels higher in the shed blood than in the autologous or homologous liquid preserved red blood cells (Table 5 ). Factor V levels were similar in shed blood and liquid preserved red blood cells (Table 5) . Shed blood exhibited higher prothrombin times (PT) and thrombin times (TT) than the autologous or homologous liquid preserved red blood cells, but partial thromboplastin times (PTT) were similar ( Table 5 ).
Plasminogen and plasmin levels were slightly higher in the shed blood than in the liquid preserved red blood cells (Table 5 ), but antithrombin III levels were similar (Table   5 ). Fibrin degradation products (FDP) and D-dimers were higher in the shed blood than in the liquid preserved red blood cells (Table 5 ). The shed blood exhibited higher concentrations of complement C3a dys arg (C3a) than the liquid preserved red blood cells (Table 5) .
Methylmethacrylate monomer (MMA) was not detectable in the shed blood samples tested.
Greater concentration of fat particles (both <10 urn diameter and 10-4 0 um diameter) were seen in the shed blood than in the liquid preserved red blood cells (Table 5 ). The RC100 filter appeared to be more effective than the 40 micron filter in removing fat particles and white blood cells ( Table 6 ). The quality of the shed blood was not At various post-surgical time points after the transfusion of the liquid preserved red blood cells, the level of fibrin degradation products (FDP) was roughly double that seen prior to surgery. In the patients who received the shed blood FDP was significantly increased one hour after transfusion to a level ten-fold that seen prior to surgery, but by 24 hours posttransfusion the levels were similar to those in the patients who received liquid preserved red blood cells (Table 7) . D-dimer levels, which
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also were increased at all post-surgical measurement times, Table 7) .
Methylmethacrylate monomer (MMA) was not detectable at any of the post-surgical time points (Table 7) . In systemic blood samples, the levels of fat particles of both sizes (less than 10 urn diameter "(Fat <10) and between 10 and 40 urn diameter (Fat 10-40)), were similar in the patients who received shed blood and those who received liquid preserved red blood cells (Table 7) . Factor VIII levels were also increased in shed blood.
The RC100 filter, designed to remove leukocytes, was more effective than the 40 urn filter in removing both fat 13 . 
